Green Cross Holding logo

Green Cross Holding

Asia, Kyongsang-bukto, South Korea, Gyeongju

Description

GC holding company, which operates pharmaceutical, biotechnology, distribution system, life insurance, and healthcare entities.

Investor Profile

Green Cross Holding has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 14% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B rounds (top funding stages).
  • Majority of deals are located in United States, Canada, South Korea.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Series A (57%)
  • Series B (43%)

Country Focus

  • United States (71%)
  • Canada (14%)
  • South Korea (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Therapeutics
  • Life Science
  • Communities
  • Mobile Apps
  • Online Portals
  • Q&a
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Green Cross Holding frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 2
E&Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Asahi Kasei Corporate Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
AQC Capital
North America, Quebec, Canada, Montréal
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Green Cross Lab Cell
Asia, Ch'ungch'ong-namdo, South Korea, Yongin
Co-Investments: 2
Adjuvant Capital
North America, New York, United States, New York
Co-Investments: 3
Anges Quebec
North America, Quebec, Canada, Quebec
Co-Investments: 1
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4

What are some of recent deals done by Green Cross Holding?

Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

BiopharmaBiotechnologyHealth CareMedical
Series BMar 17, 2025
Amount Raised: $110,000,000
Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotech firm that focuses on producing vaccines.

BiopharmaBiotechnologyHealth Care
Series ANov 16, 2022
Amount Raised: $26,000,000
MiNDCAFE

Yeoksamdong, Seoul-t'ukpyolsi, South Korea

MiNDCAFE is an online psychological counseling and mind-healing platform.

CommunitiesHealth CareMobile AppsOnline PortalsQ&A
Series BFeb 10, 2022
Amount Raised: $17,000,000
Curevo

Bothell, Washington, United States

Curevo is a clinical-stage biotech firm that focuses on producing vaccines.

BiopharmaBiotechnologyHealth Care
Series AJan 7, 2022
Amount Raised: $60,000,000
Artiva Biotherapeutics

San Diego, California, United States

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

BiotechnologyLife ScienceTherapeutics
Series BFeb 26, 2021
Amount Raised: $120,000,000
Artiva Biotherapeutics

San Diego, California, United States

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

BiotechnologyLife ScienceTherapeutics
Series AJun 26, 2020
Amount Raised: $78,000,000
Feldan Therapeutics

Quebec, Quebec, Canada

Feldan Therapeutics has developed a patented peptide-based technology platform.

BiotechnologyTherapeutics
Series ASep 18, 2018
Amount Raised: $13,800,000

Find More Investors Like Green Cross Holding

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Green Cross Holding | Pipeseed